Search

everythinglearnresearchcommunity

for

Search:↓

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

New compounds may soon be tested to treat excessive hair growth in women.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

Non-obese women with hair loss have higher heart disease risk.

Spironolactone effectively reduces symptoms of hyperandrogenism but has some side effects.

A young girl's hyperandrogenism was caused by an adrenocortical adenoma, diagnosed and treated through detailed evaluations.

Spironolactone effectively reduces symptoms of hyperandrogenism like hirsutism and acne.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

High proliferative activity and peripheral invasion indicate malignancy in canine sebaceous gland tumors; the term 'epithelioma' should be updated for clarity.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Metformin helps improve menstrual irregularities and some hormone levels in PCOS patients, but not symptoms like excess hair, acne, or hair loss.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Adolescents with abnormal uterine bleeding often have polycystic ovarian syndrome and insulin resistance.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Hormonal changes and conditions like polycystic ovarian syndrome are major causes of adult acne in women, with varying prevalence among different ethnicities.

Antiandrogens help treat hormone-related conditions in both men and women.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.